Literature DB >> 2992484

Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sarcoplasmic reticulum.

R N Harris, J H Doroshow.   

Abstract

This study investigated the effect of doxorubicin-related oxygen radical formation on Ca2+ uptake by rat heart sarcoplasmic reticulum vesicles. Enzymatic activation of doxorubicin by cardiac NADH dehydrogenase produced a dose-related inhibition of Ca2+ uptake that was enzyme- and cofactor-dependent and that was inhibited by catalase, various hydroxyl radical scavengers, and the iron chelator deferoxamine. Furthermore, inhibition of Ca2+ uptake paralleled the production of the hydroxyl radical by NADH dehydrogenase after doxorubicin treatment. These results suggest that doxorubicin-stimulated reactive oxygen metabolism can alter Ca2+ transport by cardiac sarcoplasmic reticulum and may represent one pathway involved in the cardiac toxicity of this potent antineoplastic agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992484     DOI: 10.1016/0006-291x(85)90478-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Alternative splicing generates a CaM kinase IIbeta isoform in myocardium that targets the sarcoplasmic reticulum through a putative alphaKAP and regulates GAPDH.

Authors:  Puneet Singh; John J Leddy; George J Chatzis; Maysoon Salih; Balwant S Tuana
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

2.  Myocardial Ca-sequestration failure and compensatory increase in Ca-ATPase with congestive cardiomyopathy: kinetic characterization by a homogenate microassay using real-time ratiometric indo-1 spectrofluorometry.

Authors:  P J O'Brien; H Shen; J Weiler; M Mirsalimi; R Julian
Journal:  Mol Cell Biochem       Date:  1991-03-27       Impact factor: 3.396

3.  Mitochondrial calcium in hearts subjected to lipid peroxidation with contracture development.

Authors:  K Ytrehus; S Rotevatn; E Løvaas; T Saetersdal; O D Mjøs
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

Review 4.  Pharmacology of calcium release from sarcoplasmic reticulum.

Authors:  P Palade; C Dettbarn; D Brunder; P Stein; G Hals
Journal:  J Bioenerg Biomembr       Date:  1989-04       Impact factor: 2.945

Review 5.  Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics.

Authors:  James H Doroshow
Journal:  Curr Pharm Biotechnol       Date:  2012-08       Impact factor: 2.837

6.  Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.

Authors:  B J Cusack; S P Young; R D Olson
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Extracellular superoxide dismutase regulates cardiac function and fibrosis.

Authors:  Corrine R Kliment; Hagir B Suliman; Jacob M Tobolewski; Crystal M Reynolds; Brian J Day; Xiaodong Zhu; Charles F McTiernan; Kenneth R McGaffin; Claude A Piantadosi; Tim D Oury
Journal:  J Mol Cell Cardiol       Date:  2009-08-18       Impact factor: 5.000

8.  Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat.

Authors:  E Monti; F Piccinini; F Villani; L Favalli
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

Authors:  D A Dodd; J B Atkinson; R D Olson; S Buck; B J Cusack; S Fleischer; R J Boucek
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer.

Authors:  B Sørensen; L Bastholt; M R Mirza; S B Gjedde; P Jakobsen; H T Mouridsen; C Rose
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.